School of Medicine
Showing 601-650 of 940 Results
-
Helene Chokron Garneau
Sr Research Scholar, Psych/Public Mental Health & Population Sciences
Current Role at StanfordSenior Research Scientist
Co-Director, Center for Dissemination and Implementation At Stanford (C-DIAS) -
Curtis R. Chong, MD, PhD, MPhil, FACP
Clinical Assistant Professor, Medicine - Oncology
BioDr. Chong was recruited to Stanford from the Memorial Sloan Kettering (MSK) Cancer Center, where he led MSK's launch of the early drug development and immunotherapy clinical trials program in New Jersey. At MSK, Dr. Chong was a member of the gastrointestinal oncology service and was one of two MSK physicians in New Jersey who specialized in treating melanoma. Prior to joining MSK, Dr. Chong was a member of the thoracic oncology service at the Dana-Farber Cancer Institute and an attending physician at the Massachusetts General Hospital and Brigham and Women's Hospital, all ailiates of Harvard Medical School.
Dr. Chong completed his categorical residency in internal medicine at the Massachusetts General Hospital/Harvard Medical School, his oncology fellowship at the Dana-Farber Cancer Institute, and is board-certified in internal medicine and medical oncology. He has received research support from the American Society of Clinical Oncology (Young Investigator Award), Uniting Against Lung Cancer, and the American Cancer Society. Dr. Chong has been published in the New England Journal of Medicine, Nature, Nature Medicine, Nature Chemical Biology, JAMA Oncology, and his research on drug discovery has been featured in the New York Times and Popular Science.
Born and raised in Honolulu where he attended public schools, Dr. Chong sang in the Honolulu Boy Choir, and was the 1993 Honolulu Star Bulletin Newspaper Boy of the Year. He received his A.B. in biochemical sciences from Harvard University magna cum laude followed by an M.Phil. in Chemistry with Sir Alan Fersht at the University of Cambridge (Emmanuel College). He then received his MD and PhD in pharmacology from The Johns Hopkins University School of Medicine.
An intrepid traveler and avid long-distance runner, Dr. Chong has visited 54 countries and completed 126 marathons in all 50 states, 18 countries, and 6 on continents. -
HyeRan Choo
Clinical Associate Professor, Surgery - Plastic & Reconstructive Surgery
BioDr. HyeRan Choo is a Clinical Associate Professor and Section Chief of Craniofacial Airway Orthodontics in the Department of Surgery, Division of Plastic and Reconstructive Surgery at Stanford University School of Medicine. She also serves as the Director of the Stanford Orthodontic Airway Plate Treatment Program for Pierre Robin Sequence (SOAP for PRS) at Lucile Packard Children’s Hospital Stanford and is a faculty fellow at the Stanford Mussallem Center for Biodesign.
Dr. Choo earned her dental degrees from Seoul National University (combined Undergraduate and Graduate Dental Surgery program) and The University of Pennsylvania (Dental Medicine program). She completed her Post-graduate Orthodontic Residency and Master of Science degree at The University of Alabama in Birmingham. After a Craniofacial Fellowship at the National Institutes of Health / National Institute of Dental and Craniofacial Research, Dr. Choo served as Director of Craniofacial Orthodontics at The Children’s Hospital of Philadelphia / The University of Pennsylvania.
In 2012, Dr. Choo relocated to the San Francisco Bay Area, where she became a craniofacial orthodontic provider for Kaiser Permanente Medical Centers in Oakland and Santa Clara. She joined the Stanford University faculty in 2016 as a part-time craniofacial orthodontist and clinical instructor and transitioned to a full-time position in 2019 as a craniofacial airway orthodontist and clinical assistant professor.
Her clinical expertise includes surgical and non-surgical craniofacial and airway orthodontic treatments for neonates, infants, and children with craniofacial dysmorphism and/or orofacial dysfunctions. Dr. Choo's treatment philosophy centers on providing minimally invasive yet highly effective treatments, grounded in a deep understanding of craniofacial growth and function. Her SOAP for PRS program is the first in the nation to non-surgically treat neonates with PRS using OAP, which she fabricates based on her innovative method of analyzing maxillomandibular computed tomography. -
Mehak Chopra
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioHer expertise lies in treating special populations such as athletes and students. She has also had training in dealing with cultural psychiatry issues. She has been trained to treat students with a variety of mental health issues – ADHD, Bipolar disorder, schizophrenia, eating disorders, insomnia, mood disorder and personality disorders.
-
Danny Hung-Chieh Chou
Associate Professor of Pediatrics (Endocrinology) and, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsOur research program integrates concepts of chemical biology, protein engineering and structure biology to design new therapeutic leads and generate probes to study biological processes. A key focus of our lab is insulin, an essential hormone in our body to reduce blood glucose levels. We generate synthetic libraries of insulin analogs to select for chemical probes, and investigate natural insulin molecules (e.g. from the venom of fish-hunting cone snails!) to develop novel therapeutic candidates. We are especially interested in using chemical and enzymatic synthesis to create novel chemical entities with enhanced properties, and leverage the strong expertise of our collaborators to apply our skill sets in the fields of cancer biology, immunology and pain research. Our ultimate goal is to translate our discovery into therapeutic interventions in human diseases.
-
Loretta Chou, MD
Professor of Orthopaedic Surgery
Current Research and Scholarly InterestsI am a Board Certified Orthopaedic Surgeon, subspecializing in Disorders of the Foot and Ankle. My clinic offers diagnosis and treatment of deformities and acute injuries of the foot and ankle.
My research interests include: rupture and tendinitis of the Achilles tendon, osteochondral defects of the talus, Total Ankle Arthroplasty, arthrodesis (fusion) of the foot and ankle, open fractures treated with operations, and anatomy of the foot and ankle. -
Raymond Chou, MD
Clinical Assistant Professor, Orthopaedic Surgery
BioDr. Chou is a hand and upper extremity physical medicine and rehabilitation specialist. He is a clinical assistant professor in the Department of Orthopaedic Surgery, Division of Physical Medicine & Rehabilitation at Stanford University School of Medicine.
He provides expert care for patients who require non-operative treatment for musculoskeletal and neurologic conditions affecting the shoulder, arm, wrist, and hand. For each patient, he develops a personalized, comprehensive, and compassionate care plan designed to achieve the best possible health and quality of life.
Among the conditions he manages are arthritis, carpal tunnel syndrome, rotator cuff disease, and tennis elbow. He excels at the use of ultrasound for diagnosis and evaluation. He also uses ultrasound to precisely guide treatments delivered with injections and nerve blocks.
Dr. Chou’s expertise includes electromyography (EMG) and extracorporeal shockwave therapy (ESWT). He has conducted research into the effects of electrical stimulation to improve upper extremity neurologic function in cervical spinal cord injury patients.
He has published the findings of his research in Physical Medicine & Rehabilitation, Spinal Cord, and other journals. He has co-authored chapters in the textbooks Handbook of Clinical Neurology and Basics of Musculoskeletal Ultrasound.
Dr. Chou has addressed his peers in presentations at meetings of the American Academy of Physical Medicine and Rehabilitation and the Association of Academic Physiatrists. Topics include compressive neuropathies from prolonged hospitalization during the COVID-19 pandemic, development of a virtual ultrasound curriculum for residents, extracorporeal shockwave therapy, and technology accessibility for stroke patients with limited upper extremity function.
He has earned honors from Harvard Medical School/Spaulding Rehabilitation Hospital and Northwestern University. He is a member of the American Academy of Physical Medicine & Rehabilitation and Association of Academic Physiatrists.
Dr. Chou volunteers his time and expertise to help the members of his community optimize their musculoskeletal health. -
Charlene Chow
Instructional Faculty, Physician Assistant Studies
BioCharlene Chow, PA-C is a Physician Assistant with the Urologic Oncology Department at Stanford Healthcare. She is originally from San Francisco, but obtained her Masters in Physician Assistant Studies at Oregon Health & Science University in 2013 in Portland, OR. She has a background in thoracic surgery working with lung cancer patients at Providence Portland Medical Center from 2013-2015. She then returned to the Bay Area and started with Stanford Urologic Oncology in March 2016.
She is the sole Urologic Oncology Advanced Practice Provider (APP) at the Cancer Center South Bay (CCSB) and specializes in urologic cancers including those of the bladder, prostate, kidney, ureter, testicle, and penis. Aside from seeing both new and return patients on her own and alongside physicians, she is also well versed in performing outpatient procedures such as prostate biopsies, cystoscopies, and bladder cancer treatments.
Her clinical interest lies in quality improvement. She has successfully completed the Clinical Excellent & Leadership Training (CEPT) program at Stanford, and is constantly involving herself and others in ongoing process improvement projects.
When she is not at work, she enjoys dance parties with her two young children, cooking, exercising, and spending time outdoors. -
Simon Chow
Senior Research Scientist, Orthopaedic Surgery
Current Role at StanfordLaboratory Manager, Goodman Lab.
-
Stephanie Chow
Clinical Assistant Professor, Obstetrics & Gynecology - Gynecologic Oncology
BioDr. Chow is a fellowship-trained gynecologic oncologist. She is a clinical assistant professor in the Department of Obstetrics and Gynecology, Division of Gynecologic Oncology.
She treats the full spectrum of gynecologic cancers, including cervical, endometrial, ovarian, vaginal, and vulvar. She emphasizes minimally invasive treatment and performs laparoscopic and robotic surgery.
Dr. Chow works closely with radiation oncology, genetics, and other oncologic specialists in a multidisciplinary setting to provide high quality, evidence-based, and individualized care. Dr. Chow is a strong advocate for patient education and strives to deliver compassionate care to patients and their families.
Dr. Chow has conducted extensive clinical research. Her work has focused on the role of the sentinel lymph node biopsy technique for gynecologic cancer, therapeutic vaccines for ovarian cancer, the impact of race on the development of uterine cancer, and other topics. She has published in Molecular Cancer Therapeutics, Gynecologic Oncology, Scientific Reports, and other peer-reviewed journals.
Dr. Chow has also won numerous honors and awards for her scholarship and research achievements. In fellowship, she earned the AACR Doreen J. Putrah Cancer Research Foundation Scholar-In-Training Award. She was also awarded the AAGL Recognition of Excellence in Minimally Invasive Gynecology.
Dr. Chow is a member of the Society of Gynecologic Oncology (SGO), American Association for Cancer Research (AACR), American Association of Gynecologic Laparoscopists (AAGL), and American College of Obstetricians and Gynecologists (ACOG). -
Megan Christofferson
Department Fellowship Manager, Pediatrics
Current Role at StanfordDepartment Fellowship Manager, Department of Pediatrics
-
Antonios Chronopoulos
Instructor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsMy research focuses on understanding how extracellular matrix (ECM) remodeling in liver fibrosis, particularly in the context of aging, diabetes, and metabolic-associated steatohepatitis (MASH), disrupts tissue mechanical homeostasis and drives hepatocellular carcinoma pathogenesis. The goal is to translate these mechanobiological insights into novel therapies targeting mechanotransduction to prevent or reverse fibrosis and improve patient outcomes with liver cancer and other desmoplastic tumors
-
Alvina Dor-Yan Chu
Adjunct Clinical Assistant Professor, Medicine - Immunology & Rheumatology
BioAlvina Chu, MD, is an adjunct clinical faculty member within the Division of Immunology and Rheumatology. She has practiced rheumatology for more than 10 years, specializing in treatment of a wide range of chronic inflammatory conditions including rheumatoid arthritis, lupus, vasculitis, and gout.
She holds a longstanding scientific interest in immunology, especially the role of B-cell signaling mechanisms in lupus and other autoimmune diseases.
In addition to taking care of patients in clinic and in the hospital, Dr. Chu enjoys teaching and mentoring fellows, residents, and medical students. -
Andrew Lee Chu, MD
Clinical Assistant Professor, Emergency Medicine
BioDr. Chu is a board-certified emergency medicine physician and clinical assistant professor in the Department of Emergency Medicine. He is passionate about integrating lean startup methodologies into daily academic practice and has a decade of experience leading multi-disciplinary teams in designing, developing, and launching award-winning healthcare technologies. Dr. Chu is currently working with his colleagues to build AI solutions that will improve clinical operations for the emergency department.
He is also part of the Stanford EM Partners Program (STEPP), where he evaluates and executes on promising academic-industry partnerships. He is also the co-chair for the Stanford EM Innovation Conference, the premier virtual conference on AI and innovation for the acute care space.
He completed his residency in emergency medicine at the Harvard affiliated Mass General Brigham program. He received his applied research fellowship in healthcare innovation at Harvard Medical School. He also completed the Stanford Biodesign Faculty Fellowship. He pursued a medical degree at Boston University, a Master of Public Health (MPH) degree at Harvard, and a Master of Business Administration (MBA) degree at the Quantic School of Business and Technology.
He is a member of the American College of Emergency Physicians, American Academy of Emergency Medicine, and Society of Academic Emergency Medicine. -
Constance Chu, MD
Professor of Orthopaedic Surgery (Sports Medicine)
BioDr. Constance R. Chu is Professor and Vice Chair Research, in the Department of Orthopedic Surgery at Stanford University. She is also Director of the Joint Preservation Center and Chief of Sports Medicine at the VA Palo Alto. Previously, she was the Albert Ferguson Endowed Chair and Professor of Orthopaedic Surgery at the University of Pittsburgh. She is a clinician-scientist who is both principal investigator of several projects funded by the National Institutes of Health and who has been recognized as a Castle-Connelly/US News and World Report “Top Doctor” in Orthopedic Surgery as well as on Becker’s list of Top Knee Surgeons in the United States. Her clinical practice focuses on the knee: primarily restoration and reconstruction of the ACL, menisci and cartilage. She graduated from the U.S. Military Academy at West Point and earned her medical degree from Harvard Medical School.
As Director of the multi-disciplinary Joint Preservation Center structured to seamlessly integrate the latest advances in biologics, mechanics, and imaging with comprehensive patient centered musculoskeletal and orthopedic care, Dr. Chu aims to develop a new model for health care delivery, research and education with an emphasis on health promotion and prevention. Cornerstones of this program include teamwork and a focus on personalized medicine. A central goal is to transform the clinical approach to osteoarthritis from palliation to prevention. In addition to optimizing clinical operations, outstanding research is critical to developing more effective new treatments. Towards this end, Dr. Chu is leading innovative translational research from bench to bedside in three main areas: quantitative imaging and biomarker development for early diagnosis and staging of joint and cartilage injury and degeneration; cartilage tissue engineering and stem cell based cartilage repair; and molecular and biological therapies for joint restoration and joint rejuvenation. Her research efforts have led to more than 30 professional awards and honors to include a Kappa Delta Award, considered to be the highest research honor in Orthopedic Surgery.
Dr. Chu also regularly holds leadership and committee positions in major professional organizations such as the American Association of Orthopedic Surgeons (AAOS) and the American Orthopedic Association (AOA). In her subspecialty of Orthopedic Sports Medicine, she is a past President of the Forum Sports Focus Group, a member of the Herodicus Society of leaders in Sports Medicine, and immediate past Chair of the American Orthopedic Society for Sports Medicine (AOSSM) Research Council. She is alumnus of the AOA American, British, Canadian (ABC) and the AOSSM Traveling Fellowships. -
David Chu
Veterinarian, Comparative Medicine - Veterinary Service Center
Current Role at StanfordOversee day to day operations in rodent and aquatic animal health programs including clinical medicine, health surveillance, import / export affairs, and strategic planning spreading across over a dozen facilities on and off campus. Supervise personnel engaged in rodent health surveillance enterprise. Administer veterinary care to animals in AAALAC-accredited Stanford research colonies. Participate in clinical and didactic training of residents (ACLAM sanctioned), externs, and visiting veterinary students. Provide assessments of animals prior to intrastate, interstate, and international shipments, including physical examination, review of colony history, and pertinent diagnostic tests. Review animal care and use proposals for the IACUC and coordinate the monitoring of approved research projects.
-
Derek Chu, MD
Clinical Associate Professor, Dermatology
Clinical Associate Professor (By courtesy), PediatricsBioDerek Chu, M.D., is Clinical Associate Professor of Dermatology and Pediatrics at Lucile Packard Children's Hospital. He completed his medical school and residency training at the University of Pennsylvania, followed by a pediatric dermatology fellowship at UCSF. Dr. Chu's clinical interests encompass a wide array of topics within pediatric dermatology, including vascular tumors and malformations, inflammatory skin diseases, dermato-oncology, neonatal dermatology, and procedural dermatology.
Email: derekchu@stanford.edu -
Gilbert Chu
Professor of Medicine (Oncology) and of Biochemistry
Current Research and Scholarly InterestsAfter shuttering the wet lab, we have focused on: a point-of-care device to measure blood ammonia and prevent brain damage; a human protein complex that juxtaposes and joins DNA ends for repair and V(D)J recombination; and strategies for teaching students and for reducing selection bias in educational programs.
-
Isabella Chu
Associate Director, Data Core, Center for Population Health Sciences
BioI have been with the Stanford School of Medicine since 2001. I received my MPH in Public Health from UC Berkeley in 2011 and joined The Stanford Center for Population Health Sciences (PHS) in 2016. My research interests focus on social and environmental determinants of health, particularly how the built environment, especially housing and transportation policy, promotes equitable access to the economy, education and other opportunities and can improve public health.
Road deaths have been the leading cause of child and young adult traumatic injury and death in the United States for many years and I want to better understand how better transportation policy can lead to safer streets for people on foot, bicycles and in automobiles.
I am the Associate Director of the Data Core at PHS. The PHS Data Core specializes in hosting large, rich, high risk data which are used by hundreds of researchers to answer questions in precision and population health. My primary responsibilities include overseeing governance and regulatory matters, data security, privacy and ethics and collaboration with the team of research scientists and engineers who have built the PHS Data Core platform. This platform and model have been replicated in several research universities throughout the United States.
Prior to joining PHS I initiated the Stanford Research Registry (SRR) which grew to over 4,000 members within two years and greatly facilitated research participation for both individuals with chronic disease as well as healthy controls in clinical trials and qualitative research. The SRR served as the foundation for the Patient Engagement Portal initiative which allows for bi-directional communication with the entire Stanford patient population and the general public for the purposes of recruitment for research, reporting research findings and allowing research participants to better understand the impacts of their service on the advancement of science. -
Lawrence Chu, MD, MS
Professor of Anesthesiology, Perioperative and Pain Medicine (MSD)
Current Research and Scholarly InterestsI have two lines of research, one involving educational informatics and use of technology in postgraduate medical education and another involving NIH-funded work in patient-oriented clinical research regarding opioid use and physiologic responses associated with acute and chronic exposure in humans.
For a full description of my educational informatics work, please see my website aim.stanford.edu.
My clinical research focuses on the study opiate-induced hyperalgesia in patients suffering from chronic pain.
I am currently conducting an NIH-funded five year double-blinded randomized controlled clinical study (NIGMS award 1K23GM071400-01) that prospectively examines the following hypotheses: 1) pain patients on chronic opioid therapy develop dose-dependent tolerance and/or hyperalgesia to these medications over time, 2) opiate-induced tolerance and hyperalgesia develop differently with respect to various types of pain, 3) opioid-induced hyperalgesia occurs independently of withdrawal phenomena, and 4) opiate-induced tolerance and hyperalgesia develop differently based on gender and/or ethnicity.
The study is the first quantitative and prospective examination of tolerance and hyperalgesia in pain patients and may have important implications for the rational use of opioids in the treatment of chronic pain. -
Steven Chu
William R. Kenan Jr. Professor, Professor of Molecular and Cellular Physiology and of Energy Science and Engineering
Current Research and Scholarly InterestsSynthesis, functionalization and applications of nanoparticle bioprobes for molecular cellular in vivo imaging in biology and biomedicine. Linear and nonlinear difference frequency mixing ultrasound imaging. Lithium metal-sulfur batteries, new approaches to electrochemical splitting of water. CO2 reduction, lithium extraction from salt water
-
Weihan Chu
Clinical Assistant Professor, Medicine
BioWeihan Chu, M.D., serves as a Clinical Assistant Professor at Stanford School of Medicine. He obtained his M.D. from Case Western Reserve University and completed both his internship and residency at Stanford Hospital. Since 2015, Dr. Chu has been an academic hospitalist at Stanford Health Care Tri-Valley Hospital.
As the Associate Chief Medical Officer and Medical Informatics Director at SHC Tri-Valley, Dr. Chu is committed to leveraging technology to enhance patient care. He focuses on improving patient safety, ensuring regulatory compliance, and strengthening infection control measures. Additionally, he leads the implementation of new telemedicine technologies to introduce specialty services to the hospital and drives multi-disciplinary change processes to optimize hospital workflow and outcomes.
In his personal time, Dr. Chu enjoys hiking, scuba diving, photography, and keeping up with the latest tech gadgets. -
Ian Chua
Clinical Associate Professor, Pediatrics
BioIan Chua, MD, MHPE is a bicoastal pediatric hospitalist and assistant professor of pediatrics at Stanford Children’s Health (Palo Alto, CA) and Children’s National Medical Center (Washington, DC). He completed his residency at Stanford Children’s with concentrations in medical education and quality improvement. He obtained his Masters’ in Health Professions Education at University of Illinois in Chicago. He currently directs the ACGME Fellows’ Common Core Curriculum, the PHM Fellowship Medical Education Pathway, and the Pediatric residency medical education pathway at Children’s National Medical Center. His interests have been in educational scholarship and professional development of transitional learners including junior faculty.
-
Katrin Chua
Professor of Medicine (Endocrinology, Gerontology and Metabolism)
Current Research and Scholarly InterestsOur lab is interested in understanding molecular processes that underlie aging and age-associated pathologies in mammals. We focus on a family of genes, the SIRTs, which regulate stress resistance and lifespan in lower organisms such as yeast, worms, and flies. In mammals, we recently uncovered a number of ways in which SIRT factors may contribute to cellular and organismal aging by regulating resistance to various forms of stress. We have now begun to characterize the molecular mechanisms by which these SIRT factors function. In particular, we are interested in how SIRT factors regulate chromatin, the molecular structure in which the DNA of mammalian genomes is packaged, and how such functions may link genome maintenance to stress resistance and aging.
